Modified Panax ginseng extract regulates autophagy by AMPK signaling in A549 human lung cancer cells

Hwa Seung Yoo, Jung Min Kim, Eunbi Jo, Chong Kwan Cho, Seung Yeul Lee, Hwan Su Kang, Min-Goo Lee, Pei Ying Yang, Ik Soon Jang

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Panax ginseng has been used worldwide as a traditional medicine for the treatment of cancer and other diseases. The antiproliferative activity of ginseng has been increased after enzymatic processing of ginseng saponin, which may result in the accumulation of minor saponins, such as Rh2, Rg3, compound K and protopanaxatriol type (PPT) in modified regular ginseng extract (MRGX). In the present study, the anticancer activity and the associated mechanisms of MRGX were investigated using A549 human lung cancer cells. To elucidate the mechanisms underlying the effects of MRGX, we performed a microarray analysis of gene expression in the A549 cells. Molecular mechanisms that were associated with the anticancer activity of MRGX were studied, with a special focus on the autophagy-related multiple signaling pathways in lung cancer cells. Microarray analyses elucidated autophagyrelated genes affected by MRGX. Administration of MRGX at 100 μg/ml induced punctate cytoplasmic expression of LC3, Beclin-1 and ATG5 and increased expression of endogenous LC3-II whereas 50 μg/ml did not inhibit the proliferation of A549 cells. Compared to the control cells, in cells treated with MRGX at 100 μg/ml, the level of p-Akt was increased, while that of mTOR-4EBP1 was decreased. Downregulation of mTOR and 4EBP1 in the MRGX-treated cells was found not to be a p-Ulk (S757)-dependent pathway, but a p-Ulk (S317)- dependent autophagic pathway, using AMPK. These data suggest that MRGX regulates AMPK and induces autophagy in lung cancer cells.

Original languageEnglish
Pages (from-to)3287-3296
Number of pages10
JournalOncology Reports
Volume37
Issue number6
DOIs
Publication statusPublished - 2017 Jun 1

Fingerprint

Panax
AMP-Activated Protein Kinases
Autophagy
Lung Neoplasms
Saponins
Microarray Analysis
Traditional Medicine
Cell Extracts
Down-Regulation

Keywords

  • Akt/mTOR pathway
  • AMPK pathway
  • Autophagy
  • NSCLC cells

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Yoo, H. S., Kim, J. M., Jo, E., Cho, C. K., Lee, S. Y., Kang, H. S., ... Jang, I. S. (2017). Modified Panax ginseng extract regulates autophagy by AMPK signaling in A549 human lung cancer cells. Oncology Reports, 37(6), 3287-3296. https://doi.org/10.3892/or.2017.5590

Modified Panax ginseng extract regulates autophagy by AMPK signaling in A549 human lung cancer cells. / Yoo, Hwa Seung; Kim, Jung Min; Jo, Eunbi; Cho, Chong Kwan; Lee, Seung Yeul; Kang, Hwan Su; Lee, Min-Goo; Yang, Pei Ying; Jang, Ik Soon.

In: Oncology Reports, Vol. 37, No. 6, 01.06.2017, p. 3287-3296.

Research output: Contribution to journalArticle

Yoo, HS, Kim, JM, Jo, E, Cho, CK, Lee, SY, Kang, HS, Lee, M-G, Yang, PY & Jang, IS 2017, 'Modified Panax ginseng extract regulates autophagy by AMPK signaling in A549 human lung cancer cells', Oncology Reports, vol. 37, no. 6, pp. 3287-3296. https://doi.org/10.3892/or.2017.5590
Yoo, Hwa Seung ; Kim, Jung Min ; Jo, Eunbi ; Cho, Chong Kwan ; Lee, Seung Yeul ; Kang, Hwan Su ; Lee, Min-Goo ; Yang, Pei Ying ; Jang, Ik Soon. / Modified Panax ginseng extract regulates autophagy by AMPK signaling in A549 human lung cancer cells. In: Oncology Reports. 2017 ; Vol. 37, No. 6. pp. 3287-3296.
@article{b82df234440f40d98661f9c6e3e3f37e,
title = "Modified Panax ginseng extract regulates autophagy by AMPK signaling in A549 human lung cancer cells",
abstract = "Panax ginseng has been used worldwide as a traditional medicine for the treatment of cancer and other diseases. The antiproliferative activity of ginseng has been increased after enzymatic processing of ginseng saponin, which may result in the accumulation of minor saponins, such as Rh2, Rg3, compound K and protopanaxatriol type (PPT) in modified regular ginseng extract (MRGX). In the present study, the anticancer activity and the associated mechanisms of MRGX were investigated using A549 human lung cancer cells. To elucidate the mechanisms underlying the effects of MRGX, we performed a microarray analysis of gene expression in the A549 cells. Molecular mechanisms that were associated with the anticancer activity of MRGX were studied, with a special focus on the autophagy-related multiple signaling pathways in lung cancer cells. Microarray analyses elucidated autophagyrelated genes affected by MRGX. Administration of MRGX at 100 μg/ml induced punctate cytoplasmic expression of LC3, Beclin-1 and ATG5 and increased expression of endogenous LC3-II whereas 50 μg/ml did not inhibit the proliferation of A549 cells. Compared to the control cells, in cells treated with MRGX at 100 μg/ml, the level of p-Akt was increased, while that of mTOR-4EBP1 was decreased. Downregulation of mTOR and 4EBP1 in the MRGX-treated cells was found not to be a p-Ulk (S757)-dependent pathway, but a p-Ulk (S317)- dependent autophagic pathway, using AMPK. These data suggest that MRGX regulates AMPK and induces autophagy in lung cancer cells.",
keywords = "Akt/mTOR pathway, AMPK pathway, Autophagy, NSCLC cells",
author = "Yoo, {Hwa Seung} and Kim, {Jung Min} and Eunbi Jo and Cho, {Chong Kwan} and Lee, {Seung Yeul} and Kang, {Hwan Su} and Min-Goo Lee and Yang, {Pei Ying} and Jang, {Ik Soon}",
year = "2017",
month = "6",
day = "1",
doi = "10.3892/or.2017.5590",
language = "English",
volume = "37",
pages = "3287--3296",
journal = "Oncology Reports",
issn = "1021-335X",
publisher = "Spandidos Publications",
number = "6",

}

TY - JOUR

T1 - Modified Panax ginseng extract regulates autophagy by AMPK signaling in A549 human lung cancer cells

AU - Yoo, Hwa Seung

AU - Kim, Jung Min

AU - Jo, Eunbi

AU - Cho, Chong Kwan

AU - Lee, Seung Yeul

AU - Kang, Hwan Su

AU - Lee, Min-Goo

AU - Yang, Pei Ying

AU - Jang, Ik Soon

PY - 2017/6/1

Y1 - 2017/6/1

N2 - Panax ginseng has been used worldwide as a traditional medicine for the treatment of cancer and other diseases. The antiproliferative activity of ginseng has been increased after enzymatic processing of ginseng saponin, which may result in the accumulation of minor saponins, such as Rh2, Rg3, compound K and protopanaxatriol type (PPT) in modified regular ginseng extract (MRGX). In the present study, the anticancer activity and the associated mechanisms of MRGX were investigated using A549 human lung cancer cells. To elucidate the mechanisms underlying the effects of MRGX, we performed a microarray analysis of gene expression in the A549 cells. Molecular mechanisms that were associated with the anticancer activity of MRGX were studied, with a special focus on the autophagy-related multiple signaling pathways in lung cancer cells. Microarray analyses elucidated autophagyrelated genes affected by MRGX. Administration of MRGX at 100 μg/ml induced punctate cytoplasmic expression of LC3, Beclin-1 and ATG5 and increased expression of endogenous LC3-II whereas 50 μg/ml did not inhibit the proliferation of A549 cells. Compared to the control cells, in cells treated with MRGX at 100 μg/ml, the level of p-Akt was increased, while that of mTOR-4EBP1 was decreased. Downregulation of mTOR and 4EBP1 in the MRGX-treated cells was found not to be a p-Ulk (S757)-dependent pathway, but a p-Ulk (S317)- dependent autophagic pathway, using AMPK. These data suggest that MRGX regulates AMPK and induces autophagy in lung cancer cells.

AB - Panax ginseng has been used worldwide as a traditional medicine for the treatment of cancer and other diseases. The antiproliferative activity of ginseng has been increased after enzymatic processing of ginseng saponin, which may result in the accumulation of minor saponins, such as Rh2, Rg3, compound K and protopanaxatriol type (PPT) in modified regular ginseng extract (MRGX). In the present study, the anticancer activity and the associated mechanisms of MRGX were investigated using A549 human lung cancer cells. To elucidate the mechanisms underlying the effects of MRGX, we performed a microarray analysis of gene expression in the A549 cells. Molecular mechanisms that were associated with the anticancer activity of MRGX were studied, with a special focus on the autophagy-related multiple signaling pathways in lung cancer cells. Microarray analyses elucidated autophagyrelated genes affected by MRGX. Administration of MRGX at 100 μg/ml induced punctate cytoplasmic expression of LC3, Beclin-1 and ATG5 and increased expression of endogenous LC3-II whereas 50 μg/ml did not inhibit the proliferation of A549 cells. Compared to the control cells, in cells treated with MRGX at 100 μg/ml, the level of p-Akt was increased, while that of mTOR-4EBP1 was decreased. Downregulation of mTOR and 4EBP1 in the MRGX-treated cells was found not to be a p-Ulk (S757)-dependent pathway, but a p-Ulk (S317)- dependent autophagic pathway, using AMPK. These data suggest that MRGX regulates AMPK and induces autophagy in lung cancer cells.

KW - Akt/mTOR pathway

KW - AMPK pathway

KW - Autophagy

KW - NSCLC cells

UR - http://www.scopus.com/inward/record.url?scp=85019566592&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019566592&partnerID=8YFLogxK

U2 - 10.3892/or.2017.5590

DO - 10.3892/or.2017.5590

M3 - Article

C2 - 28440448

AN - SCOPUS:85019566592

VL - 37

SP - 3287

EP - 3296

JO - Oncology Reports

JF - Oncology Reports

SN - 1021-335X

IS - 6

ER -